Neuland Laboratories Ltd
NSE:NEULANDLAB
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
5 006.9
16 250.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one NEULANDLAB stock under the Base Case scenario is 5 499.33 INR. Compared to the current market price of 14 904.95 INR, Neuland Laboratories Ltd is Overvalued by 63%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Neuland Laboratories Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for NEULANDLAB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Neuland Laboratories Ltd
Balance Sheet Decomposition
Neuland Laboratories Ltd
Current Assets | 9.2B |
Cash & Short-Term Investments | 1.2B |
Receivables | 3.7B |
Other Current Assets | 4.3B |
Non-Current Assets | 9.1B |
Long-Term Investments | 287.7m |
PP&E | 5.7B |
Intangibles | 2.8B |
Other Non-Current Assets | 321.8m |
Current Liabilities | 4.3B |
Accounts Payable | 1.9B |
Other Current Liabilities | 2.4B |
Non-Current Liabilities | 1.2B |
Long-Term Debt | 541.2m |
Other Non-Current Liabilities | 680.5m |
Earnings Waterfall
Neuland Laboratories Ltd
Revenue
|
16.4B
INR
|
Cost of Revenue
|
-7.6B
INR
|
Gross Profit
|
8.7B
INR
|
Operating Expenses
|
-4.5B
INR
|
Operating Income
|
4.3B
INR
|
Other Expenses
|
-905.6m
INR
|
Net Income
|
3.4B
INR
|
Free Cash Flow Analysis
Neuland Laboratories Ltd
INR | |
Free Cash Flow | INR |
NEULANDLAB Profitability Score
Profitability Due Diligence
Neuland Laboratories Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Neuland Laboratories Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
NEULANDLAB Solvency Score
Solvency Due Diligence
Neuland Laboratories Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Score
Neuland Laboratories Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NEULANDLAB Price Targets Summary
Neuland Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for NEULANDLAB is 17 977.5 INR with a low forecast of 15 402.5 INR and a high forecast of 21 000 INR.
Dividends
Current shareholder yield for NEULANDLAB is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
NEULANDLAB Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Neuland Laboratories Ltd. manufactures and exports bulk pharmaceutical ingredients and intermediates for the generics industry. The company is headquartered in Hyderabad, Telangana and currently employs 1,521 full-time employees. The firm is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. The firm operates through manufacture of active pharmaceutical ingredients and allied services. The firm has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products and services include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, Labetalol and Custom Manufacturing Services. The Company’s capabilities include FBRM, research and development, peptide laboratory, poly block reactors, laboratory reactors, heating and cooling systems, hazardous and wet laboratory, PID Laboratory Unit-III, PID Laboratory B-S Unit-I, and other lab equipment. The firm has 3 manufacturing facilities and one R&D facility in Hyderabad.
Contact
IPO
Employees
Officers
The intrinsic value of one NEULANDLAB stock under the Base Case scenario is 5 499.33 INR.
Compared to the current market price of 14 904.95 INR, Neuland Laboratories Ltd is Overvalued by 63%.